Plasma Resilience: Europe's Lifeline
Human plasma, a golden, protein-rich liquid making up 55% of our blood, is crucial for developing therapies for various conditions, including rare inherited disorders and immunodeficiencies.
Despite its importance, Europe's plasma supply chain is vulnerable, relying on the generosity of human donors, with over 12 million people donating plasma annually.
- Donations are governed by EU Member States' safety standards.
- International safety standards, such as the International Quality Plasma Program (IQPP), are also in place.
- Strict oversight is provided by the Plasma Protein Therapeutics Association (PPTA).
However, nearly 40% of plasma used for European medicines is imported from the United States, highlighting the need to strengthen the supply chain.
Europe's supply chain of this valuable resource is extremely vulnerable.
Author's summary: Europe relies heavily on human plasma donations.
More News
- Oklahoma lawmakers examine hazards of abandoned marijuana facilities
- ONLY ON 13: Relatives of family killed by drunk driver call for action
- Plasma resilience: Europe’s lifeline — and why we must strengthen it now
- VIDEO: Moment grain bin collapses in Martinton, Illinois
- What does Ghana need most? More lawyers or more problem solvers? - Ghana Business News
- Charlie Kirk: Courageous for His Faith
- Diane Keaton cause of death revealed
- Now is not the time to panic about low planning approvals
- New details of deadly Albany fire investigation may come later this week
- Lesufi`s Tembisa hospital stunt a new low - Solly Msimanga - POLITICS | Politicsweb